Press "Enter" to skip to content

Posts published in “Tentative Approval”

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

New tentative approval for Gilead Sciences drug sofosbuvir

0

[![sofosbuvir structure](https://www.DrugPatentWatch.com/img/drug-structure/sofosbuvir.png)](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound. Drug…

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!